Every peptide number
has a source, or it’s unknown.
PeptideOS is the all-in-one app for using peptides safely. Look up any compound and see the real evidence behind it, model exactly what a dose does in your body over the days that follow, check what interacts with what, get the reconstitution and dosing math right, and keep a private log of your protocol and bloodwork, all in one place.
And every number it shows you carries its source, or says plainly when nobody actually knows, so you are never dosing off a figure someone made up.
This is the actual half-life engine, not a picture of one. Pick a compound and a frequency and watch what the schedule does. Every other app hands you a dose; this one shows you what the dose does over time.
That zero is not a goal, it is enforced. A numeric claim without a citation fails the build and the deploy never ships. Across 75 compounds and 50 documented interactions, every figure traces to an FDA label or an indexed study, including the 54 where the honest answer turned out to be that no human data exists.
Eight tools, one standard
Everything here is built on the same rule: it shows its sources, and it says unknown when it means unknown.
Ask any other app for the source.
A confident number with nothing behind it. Ask a general chatbot for a peptide dose and it will invent one, in full sentences, with no way for you to tell. That is the norm this replaces.
Every figure carries its citation, one tap away. The AI briefing is grounded only on that cited data, so it is structurally incapable of inventing a dose. Where the research does not exist, it says so.
The safety half is free, and stays free
The interaction checker and the evidence tiers live free at peptidesafe.io. Charging someone to learn that a compound has documented harm is indefensible, so we do not.
One plan, everything in it
The full library, the half-life studio, the interaction checker, the simulator, bloodwork, the certificate reader, and the clinician report. Installs to your phone, works offline, cancel anytime.